Acrivon Therapeutics, Inc.

ACRV·NasdaqGM
Compare
1.9000−0.0100 (−0.52%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.9100
Open1.9100
Day range1.87001.9292
52-week range1.27003.5600
Off day high−1.51%
Off 52-week high−46.63%
Volume140.24K
Avg. volume (3M)338.63K
Market cap81.42M
EPS (TTM)-1.88
Forward P/E-1.16
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding42.85M
Short interest—
Earnings dateAug 14, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
ACRV CRDF ALLR APLM BBOT KZIA
Market cap 81.42M 80.91M 13.68M 62.15M 261.37M 100.67M
P/E (TTM) — — — — — —
Forward P/E -1.2 -1.9 -1.0 -32.8 -1.2 -737.9
Price/book 0.9 2.7 3.9 -14.4 0.8 3.1
Dividend yield — — — — — —
1-year change +9.20% −52.21% −43.42% +16.64% −71.12% +29.37%
Today −0.52% −3.70% −13.12% −0.84% −1.51% −1.34%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ACRV news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.